Valbiotis Stock
Price
Target price
€0.92
€0.92
-3.550%
-0.034
-3.550%
-
20.03.26 / Frankfurt
WKN: A2DS5F / Name: Valbiotis / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Valbiotis Stock
Valbiotis took a tumble today and lost -€0.034 (-3.550%).
So far the community has only identified positive things for Valbiotis stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Valbiotis in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Valbiotis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Valbiotis | -3.550% | - | - | - | - | - | - |
| Sensorion SA | 1.950% | -6.079% | 95.570% | - | - | - | - |
| Cerenis Therapeutics Holding S.A. | -2.360% | -3.120% | -6.193% | 150.808% | -9.475% | 46.118% | 237.867% |
| Genoway S.A. Inh. | 0.000% | 1.339% | -2.575% | -31.212% | -8.468% | -36.503% | -37.637% |
News
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: 2025 Financial Results
VALBIOTIS SA: 2025 Financial Results


